This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: Jens Gruber: Innovator in Gene Expression Regulation
Introduction
Jens Gruber is a notable inventor based in Amsterdam, Netherlands. He has made significant contributions to the field of gene expression regulation through his innovative research and patents. His work focuses on the use of virus-like particles for the introduction of RNA-interference (RNAi) inducing molecules into eukaryotic cells.
Latest Patents
Jens Gruber holds a patent for the invention titled "Down regulation of the gene expression by means of nucleic acid-loaded virus-like particles." This patent relates to compositions of virus-like particles designed for the introduction of RNAi-inducing molecules into eukaryotic cells. The invention also encompasses methods for the cell type-specific transduction of various eukaryotic cells with RNAi-inducing molecules. Furthermore, it addresses methods for diagnosing, preventing, and treating diseases associated with increased expression rates of endogenous genes or undesired expression of foreign nucleic acids, particularly viral nucleic acids. He has 1 patent to his name.
Career Highlights
Throughout his career, Jens Gruber has demonstrated a commitment to advancing the understanding of gene regulation. His innovative approaches have the potential to impact various medical fields, particularly in the diagnosis and treatment of diseases linked to gene expression.
Collaborations
Jens Gruber has collaborated with Wolfgang Lüke, contributing to the advancement of their shared research interests. Their partnership has fostered a productive environment for innovation and discovery.
Conclusion
Jens Gruber's work in gene expression regulation exemplifies the impact of innovative research on medical science. His contributions through patents and collaborations continue to pave the way for advancements in the field.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile